CD64 binding potential does not translate into enhanced therapeutic efficacy for anti-IL-23 antibodies under physiologically relevant conditions. - Cohen-Solal JF; Pohl CS; Cummings SM; Gygi JP; Safikhani Z; Bartocha B; Buckley CD; Dong Y; Eyerich K; Karsen SD; Lynch GR; Macoritto M; et al. (Molecular medicine (Cambridge, Mass.), 2026)